IPath Series Financials

GRN Etf  USD 27.45  0.45  1.61%   
Financial data analysis helps to validate if markets are currently mispricing IPath Series. We were able to interpolate data for nine available reported financial drivers for iPath Series B, which can be compared to its competitors. The etf experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of IPath Series to be traded at $26.63 in 90 days. Key indicators impacting IPath Series' financial strength include:
Net Expense Ratio
0.0075
3 y Sharp Ratio
0.16
  
The data published in IPath Series' official financial statements typically reflect IPath Series' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving IPath Series' quantitative information. For example, before you start analyzing numbers published by IPath accountants, it's essential to understand IPath Series' liquidity, profitability, and earnings quality within the context of the Barclays space in which it operates.

IPath Series Etf Summary

IPath Series competes with KraneShares Global, KraneShares European, KraneShares California, and Breakwave Dry. The index has the objective of providing exposure to the price of carbon as measured by the return of futures contracts on carbon emissions credits from two of the worlds major emissions-related mechanisms. Ipath Series is traded on New York Stock Exchange in the United States.
InstrumentUSA Etf View All
ExchangeNYSE ARCA Exchange
ISINUS06747C3227
CUSIP06747C322
RegionGlobal
Investment IssuerBarclays Capital
Etf FamilyBarclays
Fund CategoryStrategy
Portfolio ConcentrationTheme
BenchmarkDow Jones Industrial
Phone011 442 0711
CurrencyUSD - US Dollar

IPath Series Key Financial Ratios

IPath Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining IPath Series's current stock value. Our valuation model uses many indicators to compare IPath Series value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IPath Series competition to find correlations between indicators driving IPath Series's intrinsic value. More Info.
iPath Series B is one of the top ETFs in price to earning as compared to similar ETFs. It is rated # 4 ETF in beta as compared to similar ETFs totaling about  0.01  of Beta per Price To Earning. The ratio of Price To Earning to Beta for iPath Series B is roughly  84.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IPath Series' earnings, one of the primary drivers of an investment's value.

iPath Series B Systematic Risk

IPath Series' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. IPath Series volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on iPath Series B correlated with the market. If Beta is less than 0 IPath Series generally moves in the opposite direction as compared to the market. If IPath Series Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one iPath Series B is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of IPath Series is generally in the same direction as the market. If Beta > 1 IPath Series moves generally in the same direction as, but more than the movement of the benchmark.

IPath Series Thematic Clasifications

iPath Series B is part of several thematic ideas from Strategy ETFs to Theme ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas

IPath Series November 27, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of IPath Series help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of iPath Series B. We use our internally-developed statistical techniques to arrive at the intrinsic value of iPath Series B based on widely used predictive technical indicators. In general, we focus on analyzing IPath Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build IPath Series's daily price indicators and compare them against related drivers.
When determining whether iPath Series B offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IPath Series' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ipath Series B Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ipath Series B Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iPath Series B. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.